LONDON--(BUSINESS WIRE)--The urinary tract infection treatment market is poised to grow by USD 786.71 million during 2020-2024, progressing at a CAGR of almost 2% during the forecast period.
Worried about the impact of COVID-19 on your business? Here is an exclusive report talking about Market scenarios, Estimates, The impact of lockdown, and Customer behavior.
Get FREE Sample Report in Minutes!
The report on the urinary tract infection treatment market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the relation of UTI with several other factors leading to the rising incidence rate of UTI.
The urinary tract infection treatment market analysis includes disease type, geography, and key vendors. This study identifies the growing awareness of controlled usage of antibiotics as one of the prime reasons driving the urinary tract infection treatment market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The urinary tract infection treatment market covers the following areas:
Urinary Tract Infection Treatment Market Sizing
Urinary Tract Infection Treatment Market Forecast
Urinary Tract Infection Treatment Market Analysis
Companies Mentioned
- Abbott Laboratories
- AbbVie Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Cipla Inc.
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- SHIONOGI Co. Ltd.
Related Reports on Health Care Include:
Global Upper Respiratory Tract Infection Treatment Market- The upper respiratory tract infection treatment market is segmented by type (antibiotics, NSAIDs and nasal decongestants, and others) and geography (North America, Europe, Asia, and ROW). Click Here to Get an Exclusive Free Sample Report
Global Clostridium Difficile Treatment Market- The clostridium difficile (CDI) treatment market is segmented by product (broad-spectrum antibiotics and narrow-spectrum antibiotics) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Disease type
- Market segments
- Comparison by Disease type
- Uncomplicated UTI - Market size and forecast 2019-2024
- Complicated UTI - Market size and forecast 2019-2024
- Market opportunity by Disease type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- Asia - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- North America - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- AbbVie Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Cipla Inc.
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- SHIONOGI Co. Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
